Arbutus Biopharma Corp (ABUS)

Jun 13, 2025

Arbutus Biopharma Co. (NASDAQ:ABUS) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 13, 2025

Jun 08, 2025

Ameriprise Financial Inc. Makes New $62,000 Investment in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Jun 08, 2025

Jun 07, 2025

Bank of America Corp DE Acquires 171,906 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Jun 07, 2025

Jun 05, 2025

Millennium Management LLC Purchases 92,068 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Jun 05, 2025

May 29, 2025

Deutsche Bank AG Buys 75,212 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 29, 2025

May 22, 2025

Northern Trust Corp Has $4.35 Million Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 22, 2025

May 18, 2025

Arbutus Biopharma Reports Q1 2025 Results, Clinical Developments, and Legal Progress - MyChesCo

May 18, 2025

May 18, 2025

Mercer Global Advisors Inc. ADV Makes New Investment in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 18, 2025

May 18, 2025

Arbutus Biopharma Co. (NASDAQ:ABUS) Stake Boosted by Price T Rowe Associates Inc. MD - Defense World

May 18, 2025

May 15, 2025

Arbutus: Q1 Earnings Snapshot - CT Insider

May 15, 2025

May 14, 2025

Arbutus Biopharma Corp Reports Q1 2025 Earnings: Revenue at $1.8 Million, EPS Misses Estimate with $0.13 Loss - GuruFocus

May 14, 2025

May 14, 2025

Arbutus Biopharma earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada

May 14, 2025

May 14, 2025

Arbutus Biopharma (ABUS) Reports Mixed Q1 Results - GuruFocus

May 14, 2025

May 14, 2025

Arbutus Biopharma (ABUS) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 14, 2025

May 14, 2025

Arbutus (ABUS) Reports Lower Q1 Revenue Amid Promising Treatment Progress | ABUS Stock News - GuruFocus

May 14, 2025

May 14, 2025

Arbutus Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025

May 13, 2025

Is Editas Medicine (EDIT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

May 13, 2025

May 10, 2025

Arbutus Biopharma Showcases Promising Results for Hepatitis B Therapies at EASL Congress 2025 - MyChesCo

May 10, 2025

May 08, 2025

Wells Fargo & Company MN Acquires 21,768 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 08, 2025

May 07, 2025

Arbutus Biopharma (ABUS) Showcases Promising Data on Imdusiran and AB-101 | ABUS Stock News - GuruFocus

May 07, 2025

May 07, 2025

Arbutus Presents Clinical Trial Data from its Two HBV - GlobeNewswire

May 07, 2025

May 06, 2025

Arbutus Biopharma Co. (NASDAQ:ABUS) Shares Purchased by Barclays PLC - Defense World

May 06, 2025

May 05, 2025

Invesco Ltd. Grows Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 05, 2025

May 02, 2025

Arbutus Biopharma Corp (ABUS) is a good investment, but the stock may be overvalued - uspostnews.com

May 02, 2025

May 01, 2025

Arbutus Biopharma Corp (ABUS) With A Potential Upside Of More Than -139.44% - Stocksregister

May 01, 2025

May 01, 2025

Arbutus Biopharma Corp (ABUS) looking to reclaim success with recent performance - Sete News

May 01, 2025

May 01, 2025

Legal & General Group Plc Has $388,000 Stock Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

May 01, 2025

Apr 30, 2025

Arbutus Biopharma Corp [ABUS] Insider Activity: An Update for Investors - knoxdaily.com

Apr 30, 2025

Apr 28, 2025

Arbutus Biopharma Corp expected to post a loss of 10 cents a shareEarnings Preview - TradingView

Apr 28, 2025

Apr 26, 2025

Stock Market Recap: Arbutus Biopharma Corp (ABUS) Concludes at 3.12, a -1.58 Surge/Decline - DWinneX

Apr 26, 2025

Apr 25, 2025

Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Apr 25, 2025

Apr 24, 2025

Will Arbutus Biopharma (ABUS) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance

Apr 24, 2025

Apr 24, 2025

Arbutus Biopharma Showcases Promising Hepatitis B Research at EASL Congress - MyChesCo

Apr 24, 2025

Apr 23, 2025

Arbutus Biopharma Corp (ABUS)’s stock price in review: A technical analysis - uspostnews.com

Apr 23, 2025

Apr 23, 2025

Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025 - GlobeNewswire

Apr 23, 2025

Apr 21, 2025

Alliancebernstein L.P. Has $393,000 Stock Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 21, 2025

Apr 19, 2025

Franklin Resources Inc. Takes $301,000 Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 19, 2025

Apr 15, 2025

Arbutus Biopharma Co. (NASDAQ:ABUS) Shares Purchased by Vanguard Group Inc. - Defense World

Apr 15, 2025

Apr 14, 2025

Raymond James Financial Inc. Takes $34,000 Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 14, 2025

Apr 13, 2025

Wellington Management Group LLP Buys 16,484 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 13, 2025

Apr 12, 2025

Corebridge Financial Inc. Has $238,000 Stock Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 12, 2025

Apr 11, 2025

KLP Kapitalforvaltning AS Invests $84,000 in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 11, 2025

Apr 03, 2025

Teacher Retirement System of Texas Raises Stock Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Apr 03, 2025

Apr 02, 2025

Warminster-Based Arbutus Biopharma Lays Off Over Half of Workforce, Exits Its Headquarters - BUCKSCO.Today

Apr 02, 2025

Apr 01, 2025

Moderna (NasdaqGS:MRNA) Faces Legal Spotlight Affecting Investor Sentiment with -8% Dip Over Last Month - Yahoo Finance

Apr 01, 2025

Apr 01, 2025

Arbutus Biopharma Corp (NASDAQ: ABUS) – An Analysis Is What You Need - stocksregister.com

Apr 01, 2025

Mar 31, 2025

Layoff Tracker: Arbutus Cuts 57% of Workforce - BioSpace

Mar 31, 2025

Mar 31, 2025

Is Arbutus Biopharma (ABUS) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Mar 31, 2025